RICHMAN ERIC I purchased 13.9% of their position (5K shares) of NEUBASE THERAPEUTICS, INC. on the open market
Open‑market purchase worth $25.0K — a moderate purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 4/27/2021ACC: 0001104659-21-055582
+5K
Net shares
Net buyer
$25.0K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
5K acquired
Non-Derivative Transactions1
Common stock
Direct
Shares
+5K
Price / share
$5.00
Trade value
$25K
% of position
13.9%
4/26/2021
36.08K→41.08K
Total
Net shares
+5K
Net value
$25K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common stock Direct | 4/26/2021 | P · Purchase | +5K | $5.00 | $25K | 13.9% | 36.08K | 41.08K |
| Total | +5K | $25K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common stock
IndirectShares owned27.75K
Total
27.75K indirect27.75K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common stock | 27.75K | Indirect |
| Total | 27.75K | 27.75K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported